A healthcare AI collaboration and a bullish retail outlook lift sentiment, while a Phase 3 trial setback puts EyePoint under pressure.
Why AZN, VSXY, EYPT Stocks Are Moving Premarket Today
view original post
A healthcare AI collaboration and a bullish retail outlook lift sentiment, while a Phase 3 trial setback puts EyePoint under pressure.